75N91021C00009↗
The Emmes Company, LLC received this contract from Nih Nci, National Institutes of Health: $36.37M obligated so far for health r&d services; health care services; experimental development. It runs to 2027-05-31.
Key facts · data as of Oct 25, 2026
- Recipient
- The Emmes Company, LLC
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- Nih Nci (75N910)
- Obligated to date
- $36.37M
- Potential value
- $93.20M
- Ends
- 2027-05-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N91021C00009, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N91021C00009_7529_-NONE-_-NONE-
The Emmes Company, LLC: all federal awards · Department of Health and Human Services: spending · Nih Nci: what it buys · The follow-on: recompete brief
CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT
Up for re-bid: ends 2027-05-31. Recompete brief →
What it is
- Product or service
- Health R&D Services; Health Care Services; Experimental Development (PSC AN13)
- Industry
- Administrative Management and General Management Consulting Services (NAICS 541611)
- Contracting office
- Nih Nci (75N910)
- Competition
- Full and open competition · 2 offers received
- Pricing
- Cost plus fixed fee
- How it was bought
- Standalone contract
- Solicitation
- 75N91020R00037
- Where the work is
- Montgomery, MD · district MD-08
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
12 actions since 2023-04-13. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-01 | P00016 | Funding only | -$536.9K | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2026-07-21 | P00015 | Administrative change | $0 | EO 14398 CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2026-05-28 | P00014 | Option exercised | $9.00M | EO 14398 CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2026-05-07 | P00013 | Administrative change | $0 | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2025-07-09 | P00012 | Supplemental agreement (work within scope) | $7.00M | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2025-05-08 | P00011 | Change order | $0 | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2025-03-13 | P00010 | Option exercised | $2.20M | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2024-05-30 | P00009 | Option exercised | $8.55M | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2024-03-08 | P00008 | Funding only | $650.0K | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2023-06-06 | P00007 | Funding only | $0 | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2023-05-26 | P00006 | Option exercised | $7.96M | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
| 2023-04-13 | P00005 | Funding only | $1.55M | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗